Detailed information for compound 170520

Basic information

Technical information
  • TDR Targets ID: 170520
  • Name: 5-[[4-[(5-ethoxy-3-methylimidazo[4,5-b]pyridi n-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidin e-2,4-dione
  • MW: 412.462 | Formula: C20H20N4O4S
  • H donors: 1 H acceptors: 4 LogP: 3.01 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOc1ccc2c(n1)n(C)c(n2)COc1ccc(cc1)CC1SC(=O)NC1=O
  • InChi: 1S/C20H20N4O4S/c1-3-27-17-9-8-14-18(22-17)24(2)16(21-14)11-28-13-6-4-12(5-7-13)10-15-19(25)23-20(26)29-15/h4-9,15H,3,10-11H2,1-2H3,(H,23,25,26)
  • InChiKey: BHNIQYLHLZTUAN-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5-[[4-[(5-ethoxy-3-methyl-imidazo[4,5-b]pyridin-2-yl)methoxy]phenyl]methyl]thiazolidine-2,4-dione
  • 5-[[4-[(5-ethoxy-3-methyl-2-imidazo[4,5-b]pyridinyl)methoxy]phenyl]methyl]thiazolidine-2,4-dione
  • 5-[[4-[(5-ethoxy-3-methyl-imidazo[4,5-b]pyridin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
  • 5-[4-[(5-ethoxy-3-methyl-imidazo[4,5-b]pyridin-2-yl)methoxy]benzyl]thiazolidine-2,4-quinone
  • 5-[[4-[(5-ethoxy-3-methylimidazo[5,4-b]pyridin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
  • 5-[[4-[(5-ethoxy-3-methyl-imidazo[5,4-b]pyridin-2-yl)methoxy]phenyl]methyl]thiazolidine-2,4-dione
  • 5-[[4-[(5-ethoxy-3-methyl-2-imidazo[5,4-b]pyridinyl)methoxy]phenyl]methyl]thiazolidine-2,4-dione
  • 5-[4-[(5-ethoxy-3-methyl-imidazo[5,4-b]pyridin-2-yl)methoxy]benzyl]thiazolidine-2,4-quinone
  • 5-[[4-[(5-ethoxy-3-methyl-imidazo[5,4-b]pyridin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Toxoplasma gondii malate dehydrogenase MDH 0.098 1 0.5
Plasmodium falciparum L-lactate dehydrogenase 0.098 1 1
Leishmania major glycosomal malate dehydrogenase 0.0764 0.7621 0.4439
Echinococcus multilocularis L lactate dehydrogenase B chain 0.098 1 1
Echinococcus granulosus lactate dehydrogenase protein 0.098 1 1
Entamoeba histolytica malate dehydrogenase, putative 0.098 1 1
Trichomonas vaginalis malate and lactate dehydrogenase, putative 0.0829 0.8334 1
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Loa Loa (eye worm) malate dehydrogenase 0.0764 0.7621 0.7621
Echinococcus multilocularis malate dehydrogenase 0.0764 0.7621 0.7621
Giardia lamblia Malate dehydrogenase 0.0829 0.8334 0.5
Echinococcus multilocularis cytosolic malate dehydrogenase 0.0829 0.8334 0.8334
Echinococcus granulosus L lactate dehydrogenase B chain 0.098 1 1
Leishmania major malate dehydrogenase 0.0764 0.7621 0.4439
Echinococcus multilocularis lactate dehydrogenase a 0.098 1 1
Echinococcus granulosus cytosolic malate dehydrogenase 0.0829 0.8334 0.8334
Loa Loa (eye worm) hypothetical protein 0.098 1 1
Mycobacterium tuberculosis Probable malate dehydrogenase Mdh 0.0829 0.8334 0.5
Echinococcus multilocularis lactate dehydrogenase protein 0.098 1 1
Trichomonas vaginalis malate and lactate dehydrogenase, putative 0.0829 0.8334 1
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Loa Loa (eye worm) malate dehydrogenase 0.0829 0.8334 0.8334
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Trichomonas vaginalis malate and lactate dehydrogenase, putative 0.0829 0.8334 1
Echinococcus granulosus lactate dehydrogenase a 0.098 1 1
Trypanosoma cruzi glycosomal malate dehydrogenase, putative 0.0764 0.7621 0.7271
Trichomonas vaginalis malate dehydrogenase, putative 0.0592 0.5723 0.5611
Plasmodium vivax lactate dehydrogenase 0.098 1 1
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Echinococcus multilocularis lactate dehydrogenase a 0.098 1 1
Schistosoma mansoni malate dehydrogenase 0.0829 0.8334 0.8334
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Echinococcus multilocularis lactate dehydrogenase a 0.098 1 1
Echinococcus granulosus malate dehydrogenase 0.0764 0.7621 0.7621
Wolbachia endosymbiont of Brugia malayi malate dehydrogenase 0.098 1 0.5
Leishmania major malate dehydrogenase, putative 0.098 1 1
Leishmania major mitochondrial malate dehydrogenase 0.0764 0.7621 0.4439
Echinococcus multilocularis L lactate dehydrogenase 0.0389 0.3491 0.3491
Echinococcus granulosus L lactate dehydrogenase 0.0389 0.3491 0.3491
Plasmodium vivax malate dehydrogenase, putative 0.098 1 1
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Schistosoma mansoni L-lactate dehydrogenase 0.0592 0.5723 0.5723
Echinococcus multilocularis cytosolic malate dehydrogenase 0.0829 0.8334 0.8334
Trichomonas vaginalis malate dehydrogenase, putative 0.0525 0.4996 0.4389
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Mycobacterium ulcerans malate dehydrogenase 0.0829 0.8334 0.5
Trypanosoma cruzi glycosomal malate dehydrogenase, putative 0.0764 0.7621 0.7271
Schistosoma mansoni L-lactate dehydrogenase 0.098 1 1
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Trypanosoma brucei mitochondrial malate dehydrogenase 0.0764 0.7621 0.7271
Echinococcus granulosus malate dehydrogenase 0.0764 0.7621 0.7621
Trypanosoma brucei glycosomal malate dehydrogenase 0.0764 0.7621 0.7271
Schistosoma mansoni malate dehydrogenase 0.098 1 1
Schistosoma mansoni malate dehydrogenase 0.0829 0.8334 0.8334
Brugia malayi Probable malate dehydrogenase, mitochondrial precursor 0.0764 0.7621 0.7621
Trypanosoma cruzi mitochondrial malate dehydrogenase, putative 0.0764 0.7621 0.7271
Toxoplasma gondii lactate dehydrogenase LDH2 0.098 1 0.5
Trypanosoma cruzi cytosolic malate dehydrogenase, putative 0.0829 0.8334 1
Brugia malayi Malate dehydrogenase, cytoplasmic 0.0829 0.8334 0.8334
Trichomonas vaginalis malate and lactate dehydrogenase, putative 0.0829 0.8334 1
Toxoplasma gondii lactate dehydrogenase LDH1 0.098 1 0.5
Schistosoma mansoni malate dehydrogenase 0.0764 0.7621 0.7621
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Leishmania major cytosolic malate dehydrogenase 0.0829 0.8334 0.6105
Trichomonas vaginalis malate dehydrogenase, putative 0.0829 0.8334 1
Echinococcus granulosus lactate dehydrogenase a 0.098 1 1
Trypanosoma brucei cytosolic malate dehydrogenase 0.0829 0.8334 1
Trypanosoma cruzi cytosolic malate dehydrogenase, putative 0.0829 0.8334 1
Trypanosoma cruzi malate dehydrogenase, putative 0.0764 0.7621 0.7271
Echinococcus granulosus cytosolic malate dehydrogenase 0.0829 0.8334 0.8334
Echinococcus multilocularis malate dehydrogenase 0.0764 0.7621 0.7621
Chlamydia trachomatis malate dehydrogenase 0.0829 0.8334 0.5
Plasmodium falciparum malate dehydrogenase 0.098 1 1
Mycobacterium leprae PROBABLE MALATE DEHYDROGENASE MDH 0.0829 0.8334 0.5

Activities

Activity type Activity value Assay description Source Reference
Decrease (functional) = 23.6 % The hypoglycemic activity in diabetic KK mice,activity expressed as % decrease in blood glucose (21h) ChEMBL. 10956213
Decrease (functional) = 29.7 % The hypoglycemic activity in diabetic KK mice,activity expressed as % decrease in blood glucose (18 h) ChEMBL. 10956213
EC (functional) = 0.078 uM Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone ChEMBL. 10956213
EC (functional) = 0.078 uM Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone ChEMBL. 10956213

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.